Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Prenos Javno poročilo o oceni (PAR)
27-11-2017

Aktivna sestavina:

epirubicin hydrochloride, Quantity: 2 mg/mL

Dostopno od:

Hospira Australia Pty Ltd

INN (mednarodno ime):

epirubicin hydrochloride

Farmacevtska oblika:

Injection, solution

Sestava:

Excipient Ingredients: sodium chloride; water for injections

Pot uporabe:

Intravenous Infusion

Enote v paketu:

5 vials per pack

Razred:

Medicine Listed (Export Only)

Tip zastaranja:

(S1) This Schedule is intentionally blank

Terapevtske indikacije:

1. Relief of subjective and objective symptoms in the following diseases: Acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. Treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: Breast cancer (pre- and post-operative chemotherapy in operable cases)

Povzetek izdelek:

Visual Identification: Epirubicin Hydrochloride Injection is a clear red solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Licence status A

Datum dovoljenje:

2013-05-08